Open Access Article
This Open Access Article is licensed under a
Creative Commons Attribution 3.0 Unported Licence

Superparamagnetic nanoparticle-catalyzed coupling of 2-amino pyridines/pyrimidines with trans-chalcones

Oanh T. K. Nguyen, Pha T. Ha, Ha V. Dang, Yen H. Vo, Tung T. Nguyen, Nhan T. H. Le* and Nam T. S. Phan*
Faculty of Chemical Engineering, HCMC University of Technology, VNU-HCM, 268 Ly Thuong Kiet, District 10, Ho Chi Minh City, Vietnam. E-mail: lthnhan@hcmut.edu.vn; ptsnam@hcmut.edu.vn

Received 5th January 2019 , Accepted 4th February 2019

First published on 13th February 2019


Abstract

An aerobic coupling of 2-aminopyrimidines or 2-aminopyridines with trans-chalcones to afford aroylimidazo[1,2-a]pyrimidines and aroylimidazo[1,2-a]pyridines is reported. Reactions proceed in the presence of CuFe2O4 superparamagnetic nanoparticle catalyst, two equivalents of iodine, oxygen oxidant, and 1,4-dioxane solvent. The catalyst is superior to many common copper or iron complexes. Copper ferrite could be easily separated by magnetic decantation and reused up to 5 times without a major loss of activity. The method described here marks a rare example of using a simple, heterogeneous catalyst for synthesis of fused heterocycles. To our best knowledge, aroylimidazo[1,2-a]pyrimidines and aroylimidazo[1,2-a]pyridines were not previously synthesized using this protocol.


1. Introduction

Imidazo[1,2-a]pyridines find uses as carbene-typed ligands, organic materials, and in commercial drugs.1 Derivatization of imidazo[1,2-a]pyridines has recently emerged with regards to simple, efficient methods.2 A few prototypical derivatives such as aroylimidazo[1,2-a]pyridines are attracting attention of synthetic chemists due to potent bioactivities.1 Common methods are mostly focusing on coupling of α,β-unsaturated ketones or ketimines with 2-aminopyridines, since the starting materials are readily available or easily obtained.3 Notably, a few reports use prefunctionalized starting materials, thus limiting the practicality.4 Moreover, the use of strong bases, harsh conditions, ligand requirement, and nonreusable catalysts is notoriously challenging with regard to green chemistry. Thus, methods using simple reagents in combination with reusable catalysts for the synthesis of aroylimidazo[1,2-a]pyridines or aroylimidazo[1,2-a]pyrimidines still remain to be developed.

Nanocatalysis comprises methods of using nanoparticles to facilitate chemical transformations. Over the last two decades, significant efforts have led to the use of many nanoparticles in synthetic chemistry, bridging the gap between traditional heterogeneous and homogeneous catalysis.5 The catalytic activity of nanocatalysts is directly referred to surface areas of the particles; thus, most active sites would be readily accessible to reactants at nanometer dimension. Practicality of the nanoparticles, however, suffers from challenges of separation and recovery.5a Using superparamagnetic particles in catalysis would be a prominent solution as the nanoparticles could be recovered by magnetic decantation instead of filtration or centrifugation. Consequently, loss of the catalyst would be thwarted. Many reports of using superparamagnetic catalysts for organic reactions are known.6 Due to uniquely high activity of copper catalysis for cross couplings, the use of magnetic copper-based catalysts is exponentially growing.7 A couple of seminal reports by Glorius and co-workers emphasize a prominent role of copper impregnated on magnetite (CuO/Fe3O4) catalyst for C–H arylation.7 As our continuous interest in leveraging catalytic activity of copper ferrite nanoparticles,8 we report here a method for CuFe2O4-catalyzed coupling of 2-amino pyridines/pyrimidines with trans-chalcones to synthesize aroylimidazo[1,2-a]pyridines/aroylimidazo[1,2-a]pyrimidines (Scheme 1). The conditions allow a mild and straightforward route to prepare fused N-heterocycles in the presence of a heterogeneous catalyst, which is still limited in the literature.


image file: c9ra00097f-s1.tif
Scheme 1 Heterogeneous copper-catalyzed coupling of 2-amino pyridines/pyrimidines with chalcones.

2. Experimental section

CuFe2O4 nanoparticles were purchased from Sigma-Aldrich and used as received. A typical reaction follows the general procedure: to a pressurized vial was charged trans-chalcone (62 mg, 0.3 mmol), 2-aminopyrimidine (48 mg, 0.5 mmol), I2 (254 mg, 0.6 mmol), CuFe2O4, diphenyl ether (51 mg, 0.3 mmol) internal standard, and 1,4-dioxane (2.5 mL). The vial was heated at 140 °C for 7 h under an oxygen atmosphere. The reaction progress was monitored by withdrawing an aliquot of the reaction mixture and quenching with Na2S2O3 solution (10% v/v, 1 mL). Organic compounds then were extracted with ethyl acetate (2 mL × 2). Combined organic phases were dried over Na2SO4, filtered, and analyzed by gas chromatography.

To test the reusability of the superparamagnetic nanoparticles, the copper-iron oxide CuFe2O4 (8 mg, 30 μmol) was added to a mixture of trans-chalcone (62 mg, 0.3 mmol), 2-aminopyrimidine (48 mg, 0.5 mmol), I2 (254 mg, 0.6 mmol), and 1,4-dioxane (2.5 mL). The mixture was heated at 140 °C for 7 h under an oxygen atmosphere. The solid catalyst was collected by magnetic decantation after reaction was complete. The recovered superparamagnetic CuFe2O4 nanoparticles were carefully washed with ethyl acetate (10 mL), ethanol (10 mL), and acetone (10 mL) to remove impurities. The resulting solids were then heated at 120 °C under strong vacuum for 6 h. The catalyst was then used for a new catalytic reaction using the procedure of the first run.

Yields presented in Table 2 are isolated yields. All of the entries were done using the following procedure unless notice: to a pressurized vial was charged chalcone (0.3 mmol), 2-aminopyrimidine or 2-aminopyrimidine (0.5 mmol), I2 (254 mg, 0.6 mmol), CuFe2O4 (30 μmol, 8 mg), and 1,4-dioxane (2.5 mL). In Scheme 3, the amount of reactants and reagents were used as: dibenzylideneacetone (0.4 mmol, 94 mg), 2-aminopyridine (0.8 mmol, 75 mg), CuFe2O4 (40 μmol, 10 mg), I2 (0.8 mmol, 203 mg), 1,4-dioxane (3 mL). The vial was heated at 140 °C for 7 h under an oxygen atmosphere. The reaction progress was monitored by withdrawing an aliquot of the reaction mixture and quenching with Na2S2O3 solution (10% v/v, 1 mL). Organic compounds then were extracted with ethyl acetate (2 mL × 2). Combined organic phases were dried over Na2SO4, filtered, and concentrated. Purification by column chromatography afforded desire products. Characterization of the compounds used 1H, 13C, and 19F spectra, which were recorded on Bruker AV 500, JEOL EC-400, or JEOL EC-600 spectrometers using residual solvent peaks as references.

Table 1 Optimization conditions

image file: c9ra00097f-u1.tif

Entry Catalyst Temperature (°C) 2-Aminopyrimidine (equiv.) Solvent Yielda, %
a Trans-Chalcone (0.3 mmol), CuFe2O4 (30 μmol, 10 mol%), I2 (0.6 mmol), solvent (2.5 mL), under O2, 7 h. Yields are GC yields using diphenyl ether internal standard.b Isolated yield.c No I2.d I2 (0.45 mmol).e I2 (0.3 mmol).f CuFe2O4 (22.5 μmol, 7.5 mol%).g Under argon.h Nano oxides.
1 CuFe2O4 60 1.6 1,4-Dioxane 7
2 CuFe2O4 120 1.6 1,4-Dioxane 66
3 CuFe2O4 140 1.6 1,4-Dioxane 84, 81b
4 CuFe2O4 140 1 1,4-Dioxane 70
5 CuFe2O4 140 2.3 1,4-Dioxane 63
6 CuFe2O4 140 1.6 DMF 9
7 CuFe2O4 140 1.6 DMSO 23
8 CuFe2O4 140 1.6 Chlorobenzene 70
9c CuFe2O4 140 1.6 1,4-Dioxane 0
10d CuFe2O4 140 1.6 1,4-Dioxane 49
11e CuFe2O4 140 1.6 1,4-Dioxane 15
12f CuFe2O4 140 1.6 1,4-Dioxane 56
13 140 1.6 1,4-Dioxane 15
14g CuFe2O4 140 1.6 1,4-Dioxane 24
15 CuI 140 1.6 1,4-Dioxane 38
16 CuBr2 140 1.6 1,4-Dioxane 58
17 Cu(OAc)2 140 1.6 1,4-Dioxane 34
18 FeCl2 140 1.6 1,4-Dioxane 67
19 FeCl3 140 1.6 1,4-Dioxane 41
20 Fe2O3h 140 1.6 1,4-Dioxane 21
21 CuOh 140 1.6 1,4-Dioxane 29


Table 2 Scope of aroylimidazo[1,2-a]pyrimidine/aroylimidazo[1,2-a]pyridine synthesisa

image file: c9ra00097f-u2.tif

Entry Chalcones 2-Aminopyrimi-dines or 2-aminopyridines Products Yieldb, %
a Trans-Chalcones (0.3 mmol), 2-aminopyridines or 2-aminopyrimidine (1.6 equiv.), I2 (2 equiv.), 1,4-dioxane (2.5 mL), 140 °C, 7 h. Yields are isolated yields. Please see the ESI for details.b 2-Aminopyridine (0.5 mmol).
1 image file: c9ra00097f-u3.tif image file: c9ra00097f-u4.tif image file: c9ra00097f-u5.tif 76
2 image file: c9ra00097f-u6.tif image file: c9ra00097f-u7.tif image file: c9ra00097f-u8.tif 65
3 image file: c9ra00097f-u9.tif image file: c9ra00097f-u10.tif image file: c9ra00097f-u11.tif 67
4 image file: c9ra00097f-u12.tif image file: c9ra00097f-u13.tif image file: c9ra00097f-u14.tif 68
5 image file: c9ra00097f-u15.tif image file: c9ra00097f-u16.tif image file: c9ra00097f-u17.tif 75
6 image file: c9ra00097f-u18.tif image file: c9ra00097f-u19.tif image file: c9ra00097f-u20.tif 69
7 image file: c9ra00097f-u21.tif image file: c9ra00097f-u22.tif image file: c9ra00097f-u23.tif 70
8 image file: c9ra00097f-u24.tif image file: c9ra00097f-u25.tif image file: c9ra00097f-u26.tif 71
9 image file: c9ra00097f-u27.tif image file: c9ra00097f-u28.tif image file: c9ra00097f-u29.tif 75
10 image file: c9ra00097f-u30.tif image file: c9ra00097f-u31.tif image file: c9ra00097f-u32.tif 75
11 image file: c9ra00097f-u33.tif image file: c9ra00097f-u34.tif image file: c9ra00097f-u35.tif 73
12 image file: c9ra00097f-u36.tif image file: c9ra00097f-u37.tif image file: c9ra00097f-u38.tif 80
13 image file: c9ra00097f-u39.tif image file: c9ra00097f-u40.tif image file: c9ra00097f-u41.tif 68
14 image file: c9ra00097f-u42.tif image file: c9ra00097f-u43.tif image file: c9ra00097f-u44.tif 65
15 image file: c9ra00097f-u45.tif image file: c9ra00097f-u46.tif image file: c9ra00097f-u47.tif 65
16 image file: c9ra00097f-u48.tif image file: c9ra00097f-u49.tif image file: c9ra00097f-u50.tif 59
17 image file: c9ra00097f-u51.tif image file: c9ra00097f-u52.tif image file: c9ra00097f-u53.tif 18
18 image file: c9ra00097f-u54.tif image file: c9ra00097f-u55.tif image file: c9ra00097f-u56.tif 72
19b image file: c9ra00097f-u57.tif image file: c9ra00097f-u58.tif image file: c9ra00097f-u59.tif 63



image file: c9ra00097f-s2.tif
Scheme 2 Copper ferrite-catalyzed coupling of dibenzylideneacetone and 2-aminopyridine.

image file: c9ra00097f-s3.tif
Scheme 3 Plausible mechanism.

3. Results and discussion

The cyclization of trans-chalcone and 2-aminopyrimidine was investigated with respect to reaction temperature, amount of 2-aminopyrimidine, solvents, amount of iodine, catalyst concentration, and different copper or iron salts (Table 1). Only trace amount of the product 1 was obtained if the reaction was run at 60 °C (entry 1). Increasing temperature resulted in better yield (entries 2 and 3). At 140 °C, a complete conversion of trans-chalcone was observed. 2-Aminopyrimidine should be slightly excess to afford good yield of 1 (entry 4). Interestingly, using more than two equivalents of 2-aminopyrimidine lowered the yield (entry 5). Strongly coordinated solvents such as DMF or DMSO are not suitable for this reaction (entries 6 and 7), while chlorobenzene is inferior to 1,4-dioxane (entry 8). No product was obtained if I2 was omitted (entry 9). Using less than 2 equivalents of I2 plummeted the yield of 1 (entries 10 and 11). Low yield was also obtained if the amount of CuFe2O4 was decreased (entry 12). Running the reaction in the absence of copper ferrite gave 1 in 15% yield (entry 13). The coupling was not successful under argon atmosphere (entry 14), proving that oxygen oxidant is crucial. Such a copper-mediated aerobic transformation is known.3a,3e,3f

To highlight the prominent role of CuFe2O4 for the coupling, uses of other heterogeneous or commercial catalysts were examined. The reaction is tolerant of many copper and iron salts, albeit at lower yields (entries 15–21, Table 1). Interestingly, nanoparticles of copper or iron oxides gave product 1 in extremely low yields (entries 20 and 21). Although we could not rationalize the reason for this phenomenon, the results emphasize the synergistic effect of copper-iron cluster. It should be noted that, Glorius and co-workers, when studying the copper ferrite-catalyzed, direct C–H arylation of heteroarenes, also observed inexplicably low yields when copper and iron oxides were solely used.7a

Reaction scope is presented in Table 2. Reaction of 2-aminopyrimidine with a chloro derivative of trans-chalcone gave the product in 76% yield (entry 1). The conditions are also used to couple 2-aminopyridines with trans-chalcones (entries 2–19). Good yields are obtained regardless of electronic properties of trans-chalcones (entries 2–14). The reaction tolerates methyl, chloro, bromo, and methoxy groups. That halogenated 2-aminopyridines successfully coupled with trans-chalcone (entries 12–14) is helpful since the products could be modified via cross-coupling reactions. A 2-aminopyridine bearing carboxylate functionality gave the product in 65% yield (entry 15). With respect to the substituents on the keto moiety of chalcones, electron donating groups were superior to electron withdrawing groups (entries 16–18). The conditions are applied for synthesis of a 3-nitroimidazo[1,2-a]pyridine derivative in moderate yield (entry 19).

To confirm whether double annulation is possible or not, a highly conjugated chalcone such as dibenzylideneacetone was used to couple with 2-aminopyridine under standard conditions. The reaction only afforded 60% yield of a mono-coupling product 2 even in the presence of two equivalents of 2-aminopyridine (Scheme 2). Interestingly, a similar result was observed by Hajra and co-workers when a copper-phenanthroline system was used for the reaction.3a

A possible mechanism to obtain 3-benzoylimidazo[1,2-a]pyrimidine is presented in Scheme 3. We speculated that the reaction may proceed through the formation of some α-iodo ketone-typed compounds (ABC).3d,3g The copper iron oxide could increase the electrophilicity of the carbon–carbon double bond through binding, thus helping the first nucleophilic substitution. Oxidation of the α,β carbon–carbon single bond to form the enone-typed compound may also be facilitated by CuFe2O4 species in the presence of oxygen oxidant. Such a copper-mediated aerobic oxidation has been reported by Hajra and Kumar.3a,3e,3f The rate-determining step is perhaps the oxidation of C–C bond, since low yields were obtained in the case of electron-poor ketones. A possibility of involving iodine-free cyclocuprate species in the mechanism could be ruled out under our conditions,3a because running the reaction in the absence of iodine did not afford the desire product.

A hot filtration test was carried out to confirm the heterogeneity of the catalyst, since the formation of product 1 could be possibly attributed to soluble active species.7a The reaction of 2-aminopyrimidine and trans-chalcone proceeded in the presence of 10 mol% CuFe2O4, oxygen oxidant, and 1,4-dioxane solvent at 140 °C for 7 h. After two hours, CuFe2O4 was removed by magnetic decantation. The mother liquor was decanted and transferred to a new pressurized vial, followed by heated for additional 5 h at 140 °C. Yield of 1 did not substantially improve after the catalyst was removed, proving that leaching species if possible is negligible (Fig. 1). Notably, product 1 was obtained in 84% yield after 7 h if the magnetic copper oxide was not separated.


image file: c9ra00097f-f1.tif
Fig. 1 Kinetic profile for the coupling of 2-aminopyrimidine with trans-chalcone in the presence of CuFe2O4. The circle-dot line represents the profile when CuFe2O4 was filtered after 2 hours.

Furthermore, reusability of the copper ferrite is also investigated. The recovered CuFe2O4 nanoparticles were carefully washed with ethyl acetate, ethanol, and acetone. The copper ferrite was then heated at 120 °C under strong vacuum for 6 h. The dried particles were then used for new catalytic reactions under standard conditions. The result shows that CuFe2O4 catalyst could be reused up to 5 times, while yield of the 5th time run was still 81% (Fig. 2). Additionally, XRD analysis of the recovered CuFe2O4 revealed that the structure of the superparamagnetic nanoparticles was still maintained during the course of the reaction (Fig. 3).


image file: c9ra00097f-f2.tif
Fig. 2 Reuse of copper ferrite for the coupling of 2-aminopyrimidine with trans-chalcone.

image file: c9ra00097f-f3.tif
Fig. 3 XRD patterns of the fresh (a) and reused (b) CuFe2O4 for the coupling of 2-aminopyrimidine with trans-chalcone.

It should be noted that the methods for direct synthesis of aroylimidazo[1,2-a]pyridines and aroylimidazo[1,2-a]pyrimidines from 2-aminopyridines and 2-aminopyrimidines, respectively, are known. Some typical protocols are presented in Table 3. Until now, most of the methods still suffer from notorious challenges. For example, early works of Hajra or Kumar relied on the use of nonreusable catalyst (CuCl2) and/or an external ligand (1,10-phenanthroline).3a,3f Later, Kumar developed an one-pot method for synthesis of 3-aroylimidazo[1,2-a]pyridines which employed the excess amount of inorganic base K2CO3.3e Recently, a transition-metal-free protocol was also presented; however, the practicality of the method is still questionable since the procedure required the use of AlCl3 which is extremely moisture sensitive.3g Compared to the previous reports, our method would offer a possibility to prepare imidazo[1,2-a]pyridines towards green chemistry. The conditions use superparamagnetic CuFe2O4 nanoparticles, which are viably recoverable, for synthesis of fused N-heterocycles in good yields and high compatibility of functional groups.

Table 3 Advantages and disadvantages of available methods for coupling of 2-aminopyridines/2-aminopyrimidines and chalcones
Methods Pros Cons Reference
Cu(OAc)2 + 1,10-phenanthroline Wide scope of substrates Requirement of ligand 3a
Nonreusable catalyst
CuCl2 Ligandless conditions Nonreusable catalyst 3f
CuCl2 + K2CO3 One pot reaction Excess inorganic base 3e
I2 + AlCl3 Wide scope of substrates Moisture sensitivity 3g
Our method Wide scope of substrates    
Recoverable catalyst
No need of ligand and/or base


4. Conclusions

In conclusion, we develop a method for coupling of 2-aminopyridines or 2-aminopyrimidines with trans-chalcone to obtain aroylimidazo[1,2-a]pyrimidines and aroylimidazo[1,2-a]pyridines. Reactions proceed in the presence of CuFe2O4 catalyst, two equivalents of iodine, and 1,4-dioxane solvent. Functionalities such as methyl, methoxy, chloro, bromo, and ester groups are compatible with reaction conditions. The catalyst is superior to many common copper or iron complexes. The superparamagnetic copper oxide nanoparticles is truly heterogeneous and reusable, up to 5 times, without a major loss of structure or activity. Our method for synthesis of fused N-heterocycles is useful for later studies towards sustainable chemistry.

Conflicts of interest

There are no conflicts to declare.

Acknowledgements

The Viet Nam National Foundation for Science and Technology Development (NAFOSTED) is acknowledged for supporting this research under Project code 104.05-2018.13 (for Nhan T. H. Le).

References

  1. (a) Y. Volkova and V. Gevorgyan, Chem. Heterocycl. Compd., 2017, 53, 409 CrossRef CAS; (b) C.-H. Ke, B.-C. Kuo, D. Nandi and H. M. Lee, Organometallics, 2013, 32, 4775 CrossRef CAS; (c) A. Douhal, F. Amat-Guerri and A. U. Acuna, J. Phys. Chem., 1995, 99, 76 CrossRef CAS; (d) B. Frett, N. McConnell, A. Kharbanda, G. Naresh, B. Rounseville, C. Warner, J. Chang, N. Debolske and H.-y. Li, Tetrahedron Lett., 2018, 74, 4592 CrossRef CAS PubMed; (e) L. Almirante, L. Polo, A. Mugnaini, E. Provinciali, P. Rugarli, A. Biancotti, A. Gamba and W. Murmann, J. Org. Chem., 1965, 8, 305 CAS; (f) A. K. Bagdi, S. Santra, K. Monir and A. Hajra, Chem. Commun., 2015, 51, 1555 RSC; (g) H. G. O. Alvim, J. R. Correa, J. A. F. Assumpção, W. A. da Silva, M. O. Rodrigues, J. L. de Macedo, M. Fioramonte, F. C. Gozzo, C. C. Gatto and B. A. D. Neto, J. Org. Chem., 2018, 83, 4044 CrossRef CAS PubMed; (h) Y. Shigemitsu, T. Mutai, H. Houjou and K. Araki, Phys. Chem. Chem. Phys., 2014, 16, 14388 RSC; (i) I. Luz, F. X. Llabrés i Xamena and A. Corma, J. Catal., 2012, 285, 285 CrossRef CAS; (j) L. Jianchao and C. Qiyuan, Prog. Chem., 2010, 22, 631 Search PubMed; (k) A. R. Harris, D. M. Nason, E. M. Collantes, W. Xu, Y. Chi, Z. Wang, B. Zhang, Q. Zhang, D. L. Gray and J. E. Davoren, Tetrahedron, 2011, 67, 9063 CrossRef CAS; (l) Z. Wu, M. E. Fraley, M. T. Bilodeau, M. L. Kaufman, E. S. Tasber, A. E. Balitza, G. D. Hartman, K. E. Coll, K. Rickert, J. Shipman, B. Shi, L. Sepp-Lorenzino and K. A. Thomas, Bioorg. Med. Chem. Lett., 2004, 14, 909 CrossRef CAS PubMed; (m) T. D. Penning, N. S. Chandrakumar, B. N. Desai, S. W. Djuric, A. F. Gasiecki, J. W. Malecha, J. M. Miyashiro, M. A. Russell, L. J. Askonas, J. K. Gierse, E. I. Harding, M. K. Highkin, J. F. Kachur, S. H. Kim, D. Villani-Price, E. Y. Pyla, N. S. Ghoreishi-Haack and W. G. Smith, Bioorg. Med. Chem. Lett., 2003, 13, 1137 CrossRef CAS PubMed.
  2. (a) H. Ilda, R. Demizu and R. Ohkado, J. Org. Chem., 2018, 83, 12291 CrossRef PubMed; (b) G. Kibriya, A. K. Bagdi and A. Hajra, Org. Biomol. Chem., 2018, 16, 3473 RSC; (c) U. B. Karale, S. Kalari, J. Shivakumar, V. B. Makane, D. A. Babar, R. P. Thakare, B. N. Babu, S. Choprad and H. B. Rode, RSC Adv., 2016, 6, 65095 RSC; (d) S. Lei, Y. Mai, C. Yan, J. Mao and H. Cao, Org. Lett., 2016, 18, 3582 CrossRef CAS PubMed; (e) Y. Wu, H.-R. Zhang, R.-X. Lin, Q. Lan and X. S. Wang, Adv. Synth. Catal., 2016, 358, 3528 CrossRef CAS.
  3. (a) K. Monir, A. K. Bagdi, S. Mishra, A. Majee and A. Hajra, Adv. Synth. Catal., 2014, 356, 1105 CrossRef CAS; (b) G. Qian, B. Liu, Q. Tan, S. Zhang and B. Xu, Eur. J. Org. Chem., 2014, 4837 CrossRef CAS; (c) J. Liu, W. Wei, T. Zhao, X. Liu, J. Wu, W. Yu and J. Chang, J. Org. Chem., 2016, 81, 9326 CrossRef CAS PubMed; (d) D. Kour, A. Gupta, K. K. Kapoor, V. K. Gupta, D. Singh and P. Das, Org. Biomol. Chem., 2018, 16, 1330 RSC; (e) P. Kaswan, K. Pericherla, H. K. Saini and A. Kumar, RSC Adv., 2015, 5, 3670 RSC; (f) P. Kaswan, K. Pericherla, Rajnikant and A. Kumar, Tetrahedron, 2014, 70, 8539 CrossRef CAS; (g) M.-M. Xing, M. Xin, C. Shen, J.-R. Gao, J.-H. Jia and Y.-J. Li, Tetrahedron, 2016, 72, 4201 CrossRef CAS.
  4. (a) S. Cacchi, A. Clogli, N. Demitri, G. Fabrizi, F. Ghirga, A. Gogglamani, A. Iazzetti and D. Lamba, Synthesis, 2018, 50, 3513 CrossRef CAS; (b) J. Zeng, Y. J. Tan, M. L. Leow and X.-W. Liu, Org. Lett., 2012, 14, 4386 CrossRef CAS PubMed; (c) S. Samanta and A. Hajra, Chem. Commun., 2018, 54, 3379 RSC; (d) X. Tian, L. Song, M. Wang, Z. Lv, J. Wu, W. Yu and J. Chang, Chem. - Eur. J., 2016, 22, 7617 CrossRef CAS PubMed.
  5. For review: (a) A. Fihri, M. Bouhrara, B. Nekoueisharaki, J.-M. Besset and V. Polshiettiwar, Chem. Soc. Rev., 2011, 40, 5181 RSC; (b) D. Wang and D. Astruc, Chem. Soc. Rev., 2017, 46, 816 RSC; (c) L. Liu and A. Corma, Chem. Rev., 2018, 118, 4981 CrossRef CAS PubMed . Selected examples:; (d) F. Chen, B. Sahoo, C. Kreyenschulte, H. Lund, M. Zeng, L. He, K. Junge and M. Beller, Chem. Sci., 2017, 8, 6239 RSC; (e) D. Mateo, J. Albero and H. Garcia, Energy Environ. Sci., 2017, 10, 2392 RSC; (f) P.-H. Phua, L. Lefort, J. A. F. Boogers, M. Tristany and J. G. de Vries, Chem. Commun., 2009, 3747 RSC; (g) R. Hudson, C.-J. Li and A. Moores, Green Chem., 2012, 14, 622 RSC; (h) F. Chen, A.-E. Surkus, L. He, M.-M. Pohl, J. Radnik, C. Topf, K. Junge and M. Beller, J. Am. Chem. Soc., 2015, 137, 11718 CrossRef CAS PubMed; (i) V. Iablokov, S. K. Beaumont, S. Alayoglu, V. V. Pushkarev, C. Specht, J. Gao, A. P. Alivisatos, N. Kruse and G. A. Somorjai, Nano Lett., 2012, 12, 3091 CrossRef CAS PubMed; (j) J. Oliver-Messeguer, L. Liu, S. García-García, C. Canós-Giménez, I. Domínguez, R. Gavara, A. Doménech-Carbó, P. Concepción, A. Leyva-Pérez and A. Corma, J. Am. Chem. Soc., 2015, 137, 3894 CrossRef PubMed.
  6. For review: (a) S. Shylesh, V. Schünemann and W. R. Thiel, Angew. Chem., Int. Ed., 2010, 49, 3428 CrossRef CAS PubMed; (b) K. V. S. Ranganath and F. Glorius, Catal. Sci. Technol., 2011, 1, 13 RSC . Selected examples:; (c) A. Ying, S. Liu, Z. Li, G. Chen, J. Yang, H. Yan and S. Xu, Adv. Synth. Catal., 2016, 358, 2116 CrossRef CAS; (d) M. Afradi, N. Foroughifar, H. Pasdar and H. Moghanian, RSC Adv., 2016, 6, 59343 RSC; (e) S. Kaur, M. Kumar and V. Bhalla, Chem. Commun., 2015, 51, 16327 RSC; (f) F. M. Moghaddam, G. Tavakoli, A. Moafi, V. Saberi and H. R. Rezvani, ChemCatChem, 2014, 6, 3474 CrossRef CAS; (g) J. Liu, X. Peng, W. Sun, Y. Zhao and C. Xia, Org. Lett., 2008, 10, 3933 CrossRef CAS PubMed; (h) M. Li, B. Li, H.-F. Xia, D. Ye, J. Wu and Y. Shi, Green Chem., 2014, 16, 2680 RSC; (i) A. Hu, G. T. Yee and W. Lin, J. Am. Chem. Soc., 2005, 127, 12486 CrossRef CAS PubMed; (j) X. Cui, W. Li, P. Ryabchuk, K. Junge and M. Beller, Nat. Catal., 2018, 1, 385 CrossRef.
  7. (a) S. Vásquez-Céspedes, K. M. Chepiga, N. Möller, A. H. Schäfer and F. Glorius, ACS Catal., 2016, 6, 5954 CrossRef; (b) S. Vásquez-Céspedes, M. Holtkamp, U. Kast and F. Glorius, Synlett, 2017, 28, 2759 CrossRef; (c) G. Choudhan, D. Wang and H. Alper, Chem. Commun., 2007, 4809 RSC; (d) R. K. Sharma, Y. Monga, A. Puri and G. Gaba, Green Chem., 2013, 15, 2800 RSC; (e) R. K. Sharma, R. Gaur, M. Yadav, A. K. Rathi, J. Pechousek, M. Petr, R. Zboril and M. G. Gawande, ChemCatChem, 2015, 7, 3495 CrossRef CAS; (f) Z.-L. Wang, RSC Adv., 2015, 5, 5563 RSC; (g) J. M. Pérez and D. J. Ramón, Eur. J. Org. Chem., 2016, 2016, 4354 CrossRef.
  8. (a) P. T. Ha, O. T. K. Nguyen, K. D. Huynh, T. T. Nguyen and N. T. S. Phan, Synlett, 2018, 29, 2031 CrossRef CAS; (b) C. K. Nguyen, N. N. Nguyen, K. N. Tran, V. D. Nguyen, T. T. Nguyen, D. T. Le and N. T. S. Phan, Tetrahedron Lett., 2017, 58, 3370 CrossRef CAS; (c) C. K. Nguyen, H. H. Vu, H. V. Dang, N. N. Nguyen, N. T. H. Le and N. T. S. Phan, RSC Adv., 2017, 7, 55756 RSC; (d) O. T. K. Nguyen, L. T. Nguyen, N. K. Truong, V. D. Nguyen, A. T. Nguyen, N. T. H. Le, D. T. Le and N. T. S. Phan, RSC Adv., 2017, 7, 40929 RSC.

Footnote

Electronic supplementary information (ESI) available. See DOI: 10.1039/c9ra00097f

This journal is © The Royal Society of Chemistry 2019